COVID-19 Treatment Patent Application Doesn’t Show Utility, Federal Circuit Says
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on Feb. 18 said the U.S. Patent Trial and Appeal Board (PTAB) did not err when it upheld an examiner’s...To view the full article, register now.
Already a subscriber? Click here to view full article